BioRegenx (BRGX) Stock Price
BioRegenx Price
Over the last 25 years BioRegenx grew revenue by 16.6% annually, reaching 2.34 M USD. For BioRegenx, the net margin of -985.2% is down versus -67.5% a few years ago. The stock trades about 4,525% above its 52-week low.
BioRegenx stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of BioRegenx over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how BioRegenx stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing BioRegenx's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | BioRegenx Price |
|---|---|
| 8/3/2026 | 0.01 USD |
| 7/30/2026 | 0.01 USD |
| 7/29/2026 | 0.01 USD |
| 7/28/2026 | 0.01 USD |
| 7/27/2026 | 0.01 USD |
| 7/24/2026 | 0.01 USD |
| 7/23/2026 | 0.01 USD |
| 7/22/2026 | 0.01 USD |
| 7/21/2026 | 0.01 USD |
| 7/20/2026 | 0.01 USD |
| 7/17/2026 | 0.01 USD |
| 7/16/2026 | 0.01 USD |
| 7/15/2026 | 0.01 USD |
| 7/14/2026 | 0.01 USD |
| 7/13/2026 | 0.01 USD |
| 7/10/2026 | 0.01 USD |
| 7/9/2026 | 0.01 USD |
| 7/8/2026 | 0.01 USD |
| 7/7/2026 | 0.01 USD |
| 7/6/2026 | 0.01 USD |
| 7/3/2026 | 0.01 USD |
| 7/2/2026 | 0.01 USD |
| 7/1/2026 | 0.01 USD |
| 6/30/2026 | 0.01 USD |
| 6/29/2026 | 0.01 USD |
| 6/26/2026 | 0.01 USD |
| 6/25/2026 | 0.01 USD |
| 6/24/2026 | 0.01 USD |
| 6/23/2026 | 0.01 USD |
| 6/22/2026 | 0.01 USD |
| 6/19/2026 | 0.01 USD |
| 6/18/2026 | 0.01 USD |
| 6/17/2026 | 0.01 USD |
| 6/16/2026 | 0.01 USD |
| 6/15/2026 | 0.01 USD |
| 6/12/2026 | 0.01 USD |
| 6/11/2026 | 0.01 USD |
| 6/10/2026 | 0.01 USD |
| 6/9/2026 | 0.01 USD |
| 6/8/2026 | 0.01 USD |
| 6/5/2026 | 0.01 USD |
| 6/4/2026 | 0.01 USD |
| 6/3/2026 | 0.01 USD |
| 6/2/2026 | 0.01 USD |
| 6/1/2026 | 0.01 USD |
| 5/29/2026 | 0.01 USD |
| 5/28/2026 | 0.01 USD |
| 5/27/2026 | 0.01 USD |
| 5/26/2026 | 0.01 USD |
| 5/22/2026 | 0.01 USD |
| 5/21/2026 | 0.01 USD |
| 5/20/2026 | 0.01 USD |
| 5/19/2026 | 0.01 USD |
| 5/18/2026 | 0.01 USD |
| 5/15/2026 | 0.01 USD |
| 5/14/2026 | 0.01 USD |
| 5/13/2026 | 0.01 USD |
| 5/8/2026 | 0.01 USD |
| 5/7/2026 | 0.01 USD |
| 5/6/2026 | 0.01 USD |
| 5/5/2026 | 0.01 USD |
| 4/30/2026 | 0.01 USD |
| 4/27/2026 | 0.01 USD |
| 4/23/2026 | 0.01 USD |
| 4/21/2026 | 0.01 USD |
| 4/20/2026 | 0.01 USD |
| 4/15/2026 | 0.01 USD |
| 4/13/2026 | 0.01 USD |
| 4/8/2026 | 0.01 USD |
| 3/31/2026 | 0.01 USD |
| 3/30/2026 | 0.01 USD |
| 3/25/2026 | 0.01 USD |
| 3/24/2026 | 0.01 USD |
| 3/20/2026 | 0.01 USD |
| 3/17/2026 | 0.01 USD |
| 3/13/2026 | 0.01 USD |
| 3/11/2026 | 0.01 USD |
| 3/10/2026 | 0.01 USD |
| 3/5/2026 | 0.01 USD |
| 3/3/2026 | 0.01 USD |
| 2/24/2026 | 0.01 USD |
| 2/23/2026 | 0.02 USD |
| 2/20/2026 | 0.02 USD |
| 2/19/2026 | 0.02 USD |
| 2/18/2026 | 0.02 USD |
| 2/13/2026 | 0.01 USD |
| 2/11/2026 | 0.01 USD |
| 2/10/2026 | 0.01 USD |
| 2/5/2026 | 0.01 USD |
| 2/2/2026 | 0.01 USD |
| 1/29/2026 | 0.01 USD |
| 1/23/2026 | 0.01 USD |
| 1/20/2026 | 0.01 USD |
| 1/16/2026 | 0.01 USD |
| 1/12/2026 | 0.01 USD |
| 1/6/2026 | 0.01 USD |
| 1/5/2026 | 0.01 USD |
| 12/31/2025 | 0.01 USD |
| 12/30/2025 | 0.01 USD |
| 12/26/2025 | 0.01 USD |
| 12/22/2025 | 0.01 USD |
| 12/18/2025 | 0.01 USD |
| 12/17/2025 | 0.01 USD |
| 12/16/2025 | 0.02 USD |
| 12/12/2025 | 0.02 USD |
| 12/11/2025 | 0.01 USD |
| 12/10/2025 | 0.01 USD |
| 12/9/2025 | 0.02 USD |
| 12/3/2025 | 0.01 USD |
| 12/2/2025 | 0.01 USD |
| 12/1/2025 | 0.01 USD |
| 11/26/2025 | 0.01 USD |
| 11/25/2025 | 0.01 USD |
| 11/24/2025 | 0.02 USD |
| 11/21/2025 | 0.01 USD |
| 11/19/2025 | 0.01 USD |
| 11/14/2025 | 0.01 USD |
| 11/12/2025 | 0.01 USD |
| 11/10/2025 | 0.01 USD |
| 11/6/2025 | 0.01 USD |
| 11/4/2025 | 0.00 USD |
| 11/3/2025 | 0.01 USD |
| 10/31/2025 | 0.00 USD |
| 10/29/2025 | 0.00 USD |
| 10/28/2025 | 0.00 USD |
| 10/24/2025 | 0.00 USD |
| 10/22/2025 | 0.00 USD |
| 10/20/2025 | 0.00 USD |
| 10/17/2025 | 0.00 USD |
| 10/16/2025 | 0.00 USD |
| 10/15/2025 | 0.00 USD |
| 10/7/2025 | 0.00 USD |
| 10/3/2025 | 0.00 USD |
| 10/1/2025 | 0.00 USD |
| 9/30/2025 | 0.00 USD |
| 9/25/2025 | 0.00 USD |
| 9/24/2025 | 0.00 USD |
| 9/23/2025 | 0.00 USD |
| 9/22/2025 | 0.00 USD |
| 9/18/2025 | 0.00 USD |
| 9/17/2025 | 0.00 USD |
| 9/16/2025 | 0.00 USD |
| 9/12/2025 | 0.00 USD |
| 9/11/2025 | 0.00 USD |
| 9/9/2025 | 0.00 USD |
| 9/8/2025 | 0.00 USD |
| 9/5/2025 | 0.00 USD |
| 9/4/2025 | 0.00 USD |
| 9/2/2025 | 0.00 USD |
| 8/29/2025 | 0.00 USD |
| 8/27/2025 | 0.00 USD |
| 8/22/2025 | 0.00 USD |
| 8/21/2025 | 0.00 USD |
| 8/19/2025 | 0.00 USD |
| 8/15/2025 | 0.00 USD |
| 8/14/2025 | 0.00 USD |
| 8/13/2025 | 0.00 USD |
| 8/12/2025 | 0.00 USD |
| 8/8/2025 | 0.00 USD |
BioRegenx Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
BioRegenx Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM USD |
| EBITM USD |
| EBIT MARGIN% |
| NET INCOMEM USD |
| NET INCOME GROWTH% |
| SHARESM |
| 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | 3.00 | 2.00 |
| – | – | – | – | – | – | – | – | – | – | – | -33.33 |
| – | – | – | – | – | – | – | – | – | – | 66.67 | 50.00 |
| 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 2.00 | 1.00 |
| – | – | – | – | – | – | – | – | – | – | -3.00 | -6.00 |
| – | – | – | – | – | – | – | – | – | – | -100.00 | -300.00 |
| – | – | – | – | – | – | – | – | – | – | -3.00 | -23.00 |
| – | – | – | – | – | – | – | – | – | – | – | 666.67 |
| 939.51 | 939.51 | 939.51 | 939.51 | 939.51 | 0.01 | 0.02 | 267.96 | 269.75 | 269.75 | 639.78 | 939.51 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales BioRegenx generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue BioRegenx retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare BioRegenx's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares BioRegenx has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against BioRegenx's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
BioRegenx stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
BioRegenx Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
BioRegenx business model & stock analysis
BioRegenx SWOT Analysis
Strengths
Findit Inc has a strong brand reputation in the industry, which enhances its credibility and customer trust.
The company offers a unique and innovative platform that allows users to search and discover various types of content.
Findit Inc has a dedicated and skilled workforce, ensuring efficient operations and prompt customer service.
Weaknesses
The company has limited financial resources, which could restrict its capabilities for expansion and marketing efforts.
Findit Inc heavily relies on a few key clients for a significant portion of its revenue, creating a potential risk if these clients reduce their usage or terminate contracts.
The company's platform may face competition from larger and more established tech companies in the future.
Opportunities
The increasing adoption of social media and content sharing platforms presents an opportunity for Findit Inc to attract a wider user base.
Expansion into international markets can help Findit Inc reach a global audience and diversify its revenue streams.
Continued advancements in technology provide an opportunity for Findit Inc to enhance its platform and offer new features and services.
Threats
The constantly evolving regulatory landscape related to internet content and data privacy poses a threat to Findit Inc's operations and compliance efforts.
Intense competition from other social media and content platforms could lead to reduced market share and user engagement for Findit Inc.
Changes in user preferences and behavior towards content consumption and sharing may impact the demand for Findit Inc's platform.
BioRegenx Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
BioRegenx historical P/E ratio, EBIT multiple, and P/S ratio
BioRegenx annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
BioRegenx shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
BioRegenx stock splits
BioRegenx shareholder structure
| % | Name |
|---|---|
20.87900% | |
20.56830% | |
12.74645% | |
8.81498% | |
7.67160% | |
2.16896% |
BioRegenx Executives and Management Board
4 members · avg. age 58 · 25 % women
Mr. William Resides (56)
Chief Executive Officer, Interim Chief Financial Officer, Director · since 2024
157,500.00 USD
Ms. Suzanne Bird (60)
Director
Mr. Thomas Powers (49)
Director
Mr. Richard Janney (66)
Independent Director
Frequently asked questions about BioRegenx
Findit Inc. operates as a social media marketing platform, providing online marketing solutions for businesses. Their business model revolves around offering customized online marketing campaigns to help companies increase their online presence and reach their target audience. Leveraging various tools and technologies, Findit Inc. aims to enhance brand visibility, generate leads, and improve search engine rankings for businesses across different industries. By focusing on effective content marketing, social sharing, and search engine optimization strategies, Findit Inc. helps businesses gain exposure, attract new customers, and ultimately drive sales.
Findit Inc is primarily active in the technology and digital advertising industries.
The main competitors of Findit Inc in the market include social media platforms like Facebook, Twitter, and Instagram. These platforms also offer users the ability to share and discover content, connect with friends and followers, and promote their businesses. However, Findit Inc differentiates itself by providing a unique platform that focuses on enhancing online visibility for businesses, individuals, and content creators. With its comprehensive features and focus on search engine optimization (SEO), Findit Inc offers a distinct advantage to users who want to increase their online presence and reach a wider audience.
Findit Inc. is a renowned company specializing in online marketing solutions. Established in 1998, Findit has evolved into a leading provider of search engine optimization services, social media management, and content creation. With a strong focus on helping businesses grow their online presence, Findit offers a comprehensive suite of tools and strategies to enhance visibility and drive organic traffic. Over the years, Findit Inc. has garnered a solid reputation for delivering effective online marketing solutions and has established itself as a trusted name in the industry. With a wealth of experience and expertise, Findit Inc. continues to empower businesses to succeed in the competitive digital landscape.
Findit Inc has achieved several significant milestones throughout its history. Notably, the company introduced and developed the Findit platform, a social media content management system that provides individuals and businesses with a unique platform to share and promote their content. Findit Inc has also established various partnerships and collaborations, further expanding its reach and impact in the digital marketing industry. Additionally, the company has successfully enhanced its search engine capabilities, allowing users to easily discover and share content across different online channels. With its continuous efforts and innovative solutions, Findit Inc remains dedicated to empowering users and helping them maximize their online presence.
Findit Inc is primarily present in the United States.
Findit Inc represents a strong set of values and corporate philosophy. As a company, Findit Inc prioritizes innovation, integrity, and customer satisfaction. They strive to continuously develop groundbreaking solutions for their clients, ensuring their success in the digital landscape. Findit Inc believes in transparent, ethical business practices, acting with honesty and integrity in all their interactions. They are committed to providing exceptional products and services that help businesses effectively market themselves online. Through their dedication to excellence and customer-centric approach, Findit Inc aims to establish long-lasting partnerships and contribute to the success of their clients.
Converted at the current exchange rate, the BioRegenx share trades at 0.01 EUR (0.01 USD).
Findit Inc is an innovative company that specializes in developing online marketing solutions for businesses and individuals. Its business model goes beyond simply providing advertising space and offers a variety of services and products to its customers. The main products of Findit are Findit Prime and Findit Premium. These products provide unique opportunities for businesses and customers in online marketing. Findit Prime offers businesses the opportunity to enhance their online presence by providing them with a platform for hosting content. The focus of Findit Prime is on SEO-optimized posts that can be read by a wide audience. Findit Premium offers comprehensive online marketing opportunities to its customers, from SEO-optimized posts to social media campaigns. Findit Premium is typically designed for businesses that require a more comprehensive marketing strategy. Findit Inc also offers a range of paid and free products to help its customers take their online presence and marketing to the next level. Findit Health and Wellness, Findit.com, and Gaylord Security are just some of the services that Findit offers. These services provide businesses with the opportunity to enhance their online presence by engaging in targeted content marketing, placing targeted advertisements, and reaching their customers more effectively. With Findit.com, Findit Inc. has an online network that already has a massive reach and is visited by thousands of users every month. The network provides businesses and customers with a platform for creating and sharing content. Findit.com is also a valuable tool for creating backlinks, which can help businesses improve their online presence. In addition, Findit also offers a white-label solution for businesses that want to offer their customers their own online marketing platform. Clients of Findit can use their own branding on the platform, thus maintaining their brand identity. In addition to online marketing services, Findit Inc. also provides services for the real estate industry. Using the latest technologies, Findit delivers unique solutions for real estate agents' marketing needs. This includes online property listings, marketing properties on social media, and placing targeted ads on advertising networks. The business model of Findit Inc. is simple and well-structured: with a wide range of online marketing solutions and products tailored to the specific needs of businesses of various sizes, Findit supports its customers in reaching a broader audience and taking their marketing to a higher level.
The revenue cannot currently be calculated for BioRegenx.
The profit cannot currently be calculated for BioRegenx.
The P/E ratio cannot be calculated for BioRegenx at the moment.
The P/S cannot be calculated for BioRegenx currently.
The Eulerpool Quality Score for BioRegenx is 4/10.
The ISIN of BioRegenx is US31772N1000. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of BioRegenx is A14PEX. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of BioRegenx is BRGX. The ticker symbol is used to trade BioRegenx shares on the stock exchange.
BioRegenx paid dividends every year for the past 0 years.
BioRegenx is assigned to the 'Communication' sector.
The dividends of BioRegenx are distributed in USD.
BioRegenx stock
BioRegenx Peer Group
BioRegenx Ticker
BioRegenx FIGI
All fundamentals and in-depth analysis of BioRegenx
Our stock analysis for BioRegenx stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioRegenx. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.